{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:47:47Z","timestamp":1784155667599,"version":"3.55.0"},"reference-count":24,"publisher":"Royal College of Psychiatrists","issue":"2","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>The prescribing of psychotropic medications for people with an intellectual disability has changed. In many locations across England, antidepressants have become the most widely prescribed psychotropic. In the context of the current NHS England STOMP programme to reduce inappropriate psychotropic prescribing for people with intellectual disability, there is an urgent need to understand whether this change reflects evidence-based use of the medications involved. There has been little analysis into the benefits or problems associated with the change and whether it is of concern. This paper offers a variety of possible explanations and opportunities to improve clinical practice and policy.<\/jats:p>","DOI":"10.1192\/bjp.2022.34","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T08:05:44Z","timestamp":1646640344000},"page":"488-493","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":39,"title":["Antidepressant prescribing for adult people with an intellectual disability living in England"],"prefix":"10.1192","volume":"221","author":[{"given":"David","family":"Branford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-6933","authenticated-orcid":false,"given":"Rohit","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"S0007125022000344_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.2006.00935.x"},{"key":"S0007125022000344_ref17","volume-title":"Dependence and Withdrawal associated with Some Prescribed Medicines: An Evidence Review","author":"Taylor","year":"2019"},{"key":"S0007125022000344_ref13","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2020.97"},{"key":"S0007125022000344_ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14475"},{"key":"S0007125022000344_ref2","volume-title":"Winterbourne View Hospital: A Serious Case Review","year":"2012"},{"key":"S0007125022000344_ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jar.12635"},{"key":"S0007125022000344_ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bld.12272"},{"key":"S0007125022000344_ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4326"},{"key":"S0007125022000344_ref1","volume-title":"Doctors Urged to Help Stop \u2018Chemical Restraint\u2019 as Leading Health Professionals Sign Joint Pledge","year":"2016"},{"key":"S0007125022000344_ref4","volume-title":"Prescribing of Psychotropic Drugs to People with Learning Disabilities and\/or Autism by General Practitioners in England","author":"Glover","year":"2015"},{"key":"S0007125022000344_ref18","unstructured":"18 Learning Disabilities Mortality Review Team. The Learning Disabilities Mortality Review (LeDeR) Programme: Annual Report 2020. Learning Disabilities Mortality Review Programme, 2021 (https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2021\/06\/LeDeR-bristol-annual-report-2020.pdf)."},{"key":"S0007125022000344_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30191-2"},{"key":"S0007125022000344_ref19","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2018.000009"},{"key":"S0007125022000344_ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204178"},{"key":"S0007125022000344_ref8","volume-title":"Health and Care of People with Learning Disabilities Experimental Statistics 2019 to 2020","year":"2021"},{"key":"S0007125022000344_ref10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.022483"},{"key":"S0007125022000344_ref3","volume-title":"Psychotropic Drugs and People with Learning Disabilities or Autism","author":"Mehta","year":"2019"},{"key":"S0007125022000344_ref6","volume-title":"Prescriptions Dispensed in the Community - Statistics for England, 2006\u20132016","year":"2017"},{"key":"S0007125022000344_ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.6.523"},{"key":"S0007125022000344_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpsy.2021.10.002"},{"key":"S0007125022000344_ref9","volume-title":"Mental Health and Wellbeing in England: Adult Psychiatric Morbidity Survey 2014","author":"McManus","year":"2016"},{"key":"S0007125022000344_ref22","doi-asserted-by":"publisher","DOI":"10.1111\/bld.12206"},{"key":"S0007125022000344_ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-036862"},{"key":"S0007125022000344_ref7","volume-title":"Health and Care of People with Learning Disabilities Experimental Statistics 2020 to 2021","year":"2021"}],"container-title":["The British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125022000344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T11:24:01Z","timestamp":1666956241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125022000344\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0007125022000344"],"URL":"https:\/\/doi.org\/10.1192\/bjp.2022.34","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"Copyright \u00a9 The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}